Cargando…

Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study

BACKGROUND: The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and insidiously. Coronavirus disease 2019 (COVID-19) screening is an important means of blocking community transmission in China, but the costs associated with testing are high. Quarantine...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yun, Liu, Yuanhua, Duan, Mengwei, Xie, Xiyang, Hong, Jie, Huang, Jiaqi, Li, Ke, Shi, Jin, Chen, Xi, Guo, Hongyan, Zhou, Xuan, Liu, Rui, Zhou, Caifeng, Wang, Xiaozhe, Kong, Lingcai, Zhang, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841147/
https://www.ncbi.nlm.nih.gov/pubmed/36642738
http://dx.doi.org/10.1186/s40249-022-01049-w
_version_ 1784869769090957312
author Yin, Yun
Liu, Yuanhua
Duan, Mengwei
Xie, Xiyang
Hong, Jie
Huang, Jiaqi
Li, Ke
Shi, Jin
Chen, Xi
Guo, Hongyan
Zhou, Xuan
Liu, Rui
Zhou, Caifeng
Wang, Xiaozhe
Kong, Lingcai
Zhang, Zhijie
author_facet Yin, Yun
Liu, Yuanhua
Duan, Mengwei
Xie, Xiyang
Hong, Jie
Huang, Jiaqi
Li, Ke
Shi, Jin
Chen, Xi
Guo, Hongyan
Zhou, Xuan
Liu, Rui
Zhou, Caifeng
Wang, Xiaozhe
Kong, Lingcai
Zhang, Zhijie
author_sort Yin, Yun
collection PubMed
description BACKGROUND: The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and insidiously. Coronavirus disease 2019 (COVID-19) screening is an important means of blocking community transmission in China, but the costs associated with testing are high. Quarantine capacity and medical resources are also threatened. Therefore, we aimed to evaluate different screening strategies to balance outbreak control and consumption of resources. METHODS: A community network of 2000 people, considering the heterogeneities of household size and age structure, was generated to reflect real contact networks, and a stochastic individual-based dynamic model was used to simulate SARS-CoV-2 transmission and assess different whole-area nucleic acid screening strategies. We designed a total of 87 screening strategies with different sampling methods, frequencies of screening, and timings of screening. The performance of these strategies was comprehensively evaluated by comparing the cumulative infection rates, the number of tests, and the quarantine capacity and consumption of medical resource, which were expressed as medians (95% uncertainty intervals, 95% UIs). RESULTS: To implement COVID-19 nucleic acid testing for all people (Full Screening), if the screening frequency was four times/week, the cumulative infection rate could be reduced to 13% (95% UI: 1%, 51%), the miss rate decreased to 2% (95% UI: 0%, 22%), and the quarantine and medical resource consumption was lower than higher-frequency Full Screening or sampling screening. When the frequency of Full Screening increased from five to seven times/week (which resulted in a 2581 increase in the number of tests per positive case), the cumulative infection rate was only reduced by 2%. Screening all people weekly by splitting them equally into seven batches could reduce infection rates by 73% compared to once per week, which was similar to Full Screening four times/week. Full Screening had the highest number of tests per positive case, while the miss rate, number of tests per positive case, and hotel quarantine resource consumption in Household-based Sampling Screening scenarios were lower than Random Sampling Screening. The cumulative infection rate of Household-based Sampling Screening or Random Sampling Screening seven times/week was similar to that of Full Screening four times/week. CONCLUSIONS: If hotel quarantine, hospital and shelter hospital capacity are seriously insufficient, to stop the spread of the virus as early as possible, high-frequency Full Screening would be necessary, but intermediate testing frequency may be more cost-effective in non-extreme situations. Screening in batches is recommended if the testing capacity is low. Household-based Sampling Screening is potentially a promising strategy to implement. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-022-01049-w.
format Online
Article
Text
id pubmed-9841147
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98411472023-01-17 Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study Yin, Yun Liu, Yuanhua Duan, Mengwei Xie, Xiyang Hong, Jie Huang, Jiaqi Li, Ke Shi, Jin Chen, Xi Guo, Hongyan Zhou, Xuan Liu, Rui Zhou, Caifeng Wang, Xiaozhe Kong, Lingcai Zhang, Zhijie Infect Dis Poverty Research Article BACKGROUND: The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads rapidly and insidiously. Coronavirus disease 2019 (COVID-19) screening is an important means of blocking community transmission in China, but the costs associated with testing are high. Quarantine capacity and medical resources are also threatened. Therefore, we aimed to evaluate different screening strategies to balance outbreak control and consumption of resources. METHODS: A community network of 2000 people, considering the heterogeneities of household size and age structure, was generated to reflect real contact networks, and a stochastic individual-based dynamic model was used to simulate SARS-CoV-2 transmission and assess different whole-area nucleic acid screening strategies. We designed a total of 87 screening strategies with different sampling methods, frequencies of screening, and timings of screening. The performance of these strategies was comprehensively evaluated by comparing the cumulative infection rates, the number of tests, and the quarantine capacity and consumption of medical resource, which were expressed as medians (95% uncertainty intervals, 95% UIs). RESULTS: To implement COVID-19 nucleic acid testing for all people (Full Screening), if the screening frequency was four times/week, the cumulative infection rate could be reduced to 13% (95% UI: 1%, 51%), the miss rate decreased to 2% (95% UI: 0%, 22%), and the quarantine and medical resource consumption was lower than higher-frequency Full Screening or sampling screening. When the frequency of Full Screening increased from five to seven times/week (which resulted in a 2581 increase in the number of tests per positive case), the cumulative infection rate was only reduced by 2%. Screening all people weekly by splitting them equally into seven batches could reduce infection rates by 73% compared to once per week, which was similar to Full Screening four times/week. Full Screening had the highest number of tests per positive case, while the miss rate, number of tests per positive case, and hotel quarantine resource consumption in Household-based Sampling Screening scenarios were lower than Random Sampling Screening. The cumulative infection rate of Household-based Sampling Screening or Random Sampling Screening seven times/week was similar to that of Full Screening four times/week. CONCLUSIONS: If hotel quarantine, hospital and shelter hospital capacity are seriously insufficient, to stop the spread of the virus as early as possible, high-frequency Full Screening would be necessary, but intermediate testing frequency may be more cost-effective in non-extreme situations. Screening in batches is recommended if the testing capacity is low. Household-based Sampling Screening is potentially a promising strategy to implement. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-022-01049-w. BioMed Central 2023-01-16 /pmc/articles/PMC9841147/ /pubmed/36642738 http://dx.doi.org/10.1186/s40249-022-01049-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yin, Yun
Liu, Yuanhua
Duan, Mengwei
Xie, Xiyang
Hong, Jie
Huang, Jiaqi
Li, Ke
Shi, Jin
Chen, Xi
Guo, Hongyan
Zhou, Xuan
Liu, Rui
Zhou, Caifeng
Wang, Xiaozhe
Kong, Lingcai
Zhang, Zhijie
Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
title Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
title_full Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
title_fullStr Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
title_full_unstemmed Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
title_short Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
title_sort optimizing the nucleic acid screening strategy to mitigate regional outbreaks of sars-cov-2 omicron variant in china: a modeling study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841147/
https://www.ncbi.nlm.nih.gov/pubmed/36642738
http://dx.doi.org/10.1186/s40249-022-01049-w
work_keys_str_mv AT yinyun optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT liuyuanhua optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT duanmengwei optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT xiexiyang optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT hongjie optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT huangjiaqi optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT like optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT shijin optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT chenxi optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT guohongyan optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT zhouxuan optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT liurui optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT zhoucaifeng optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT wangxiaozhe optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT konglingcai optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy
AT zhangzhijie optimizingthenucleicacidscreeningstrategytomitigateregionaloutbreaksofsarscov2omicronvariantinchinaamodelingstudy